Pour aller plus loin
Boyd, M.J., Berthelette, C., Chiasson, J.F., Clark, P., Colucci, J., Denis, D., Han, Y., Levesque, J.F., Mathieu, M.C., Stocco, R., Therien, A., Rowland, S., Wrona, M. & Xu, D. (2011) A novel series of potent and selective EP4 receptor ligands: facile modulation of agonism and antagonism. Bioorganic and Medicinal Chemistry Letters, 21, 484–487.
De Vito, V., Saba, A., Lee, H.K., Owen, H., Poapolathep, A. & Giorgi, M. (2015) Detection and quantification of the selective EP4 receptor antagonist CJ-023423 (grapiprant) in canine plasma by HPLC with spectrofluorimetric detection. Journal of Pharmaceutical and Biomedical
Analysis, 118, 251–258.
Dong, H., Sun, H., Magal, E., Ding, X., Kumar, G.N., Chen, J.J., Johnson, E.J. & Manning, B.H. (2008) Inflammatory pain in the rabbit: a new, efficient method for measuring mechanical hyperalgesia in the hind paw. Journal of Neuroscience Methods, 168, 76–87.
Murase, A., Okumura, T., Sakakibara, A., Tonai-Kachi, H., Nakao, K. & Takada, J. (2008) Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. European Journal of Pharmacology, 580, 116–121.
Nagahisa, A. & Okumura, T. (2017) Pharmacology of grapiprant, a novel EP4 antagonist: receptor binding, efficacy in a rodent postoperative pain model, and a dose estimation for controlling pain in dogs. Journal of Veterinary Pharmacology and Therapeutics, 40,
285–292.